Interpreting serological tests in diagnosing autoimmune liver diseases

Pietro Invernizzi, Ana Lleo, Mauro Podda

Research output: Contribution to journalArticle

81 Citations (Scopus)

Abstract

Autoimmune liver diseases (ALD) are characterized by immune-mediated injury of bile ducts or hepatocytes, thus including cholangiopathies such as primary biliary cirrhosis (PBC), primary sclerosing cholangitis, and autoimmune hepatitis. Further, ALD variants manifesting with both hepatocellular and cholangiocellular damage are becoming more common. Serum autoantibodies, together with imaging and histology, are critical to the diagnostic process when ALD is suspected. Because an early diagnosis can influence prognosis, the development of sensitive and specific tests for serum autoantibodies should he a priority for researchers to ensure a more efficient noninvasive workup. Little prognostic value has been observed for any of the ALD serum hallmarks, and a vigorous effort to investigate new and old markers should therefore be undertaken in longitudinal studies as in the recent paradigm of PBC-specific antinuclear antibodies. We review herein the numerous ALD screening tests available in routine and specialized laboratories and comment on their significance in clinical practice.

Original languageEnglish (US)
Pages (from-to)161-172
Number of pages12
JournalSeminars in Liver Disease
Volume27
Issue number2
DOIs
StatePublished - May 2007
Externally publishedYes

Fingerprint

Serologic Tests
Autoimmune Diseases
Liver Diseases
Biliary Liver Cirrhosis
Autoantibodies
Serum
Autoimmune Hepatitis
Sclerosing Cholangitis
Antinuclear Antibodies
Bile Ducts
Longitudinal Studies
Early Diagnosis
Hepatocytes
Histology
Research Personnel
Wounds and Injuries

Keywords

  • Autoimmune hepatitis
  • Overlap syndromes
  • Primary biliary cirrhosis
  • Primary sclerosing cholangitis
  • Serum autoantibodies

ASJC Scopus subject areas

  • Hepatology

Cite this

Interpreting serological tests in diagnosing autoimmune liver diseases. / Invernizzi, Pietro; Lleo, Ana; Podda, Mauro.

In: Seminars in Liver Disease, Vol. 27, No. 2, 05.2007, p. 161-172.

Research output: Contribution to journalArticle

Invernizzi, Pietro ; Lleo, Ana ; Podda, Mauro. / Interpreting serological tests in diagnosing autoimmune liver diseases. In: Seminars in Liver Disease. 2007 ; Vol. 27, No. 2. pp. 161-172.
@article{2c1357684ead422997077e8e7d5d4342,
title = "Interpreting serological tests in diagnosing autoimmune liver diseases",
abstract = "Autoimmune liver diseases (ALD) are characterized by immune-mediated injury of bile ducts or hepatocytes, thus including cholangiopathies such as primary biliary cirrhosis (PBC), primary sclerosing cholangitis, and autoimmune hepatitis. Further, ALD variants manifesting with both hepatocellular and cholangiocellular damage are becoming more common. Serum autoantibodies, together with imaging and histology, are critical to the diagnostic process when ALD is suspected. Because an early diagnosis can influence prognosis, the development of sensitive and specific tests for serum autoantibodies should he a priority for researchers to ensure a more efficient noninvasive workup. Little prognostic value has been observed for any of the ALD serum hallmarks, and a vigorous effort to investigate new and old markers should therefore be undertaken in longitudinal studies as in the recent paradigm of PBC-specific antinuclear antibodies. We review herein the numerous ALD screening tests available in routine and specialized laboratories and comment on their significance in clinical practice.",
keywords = "Autoimmune hepatitis, Overlap syndromes, Primary biliary cirrhosis, Primary sclerosing cholangitis, Serum autoantibodies",
author = "Pietro Invernizzi and Ana Lleo and Mauro Podda",
year = "2007",
month = "5",
doi = "10.1055/s-2007-979469",
language = "English (US)",
volume = "27",
pages = "161--172",
journal = "Seminars in Liver Disease",
issn = "0272-8087",
publisher = "Thieme Medical Publishers",
number = "2",

}

TY - JOUR

T1 - Interpreting serological tests in diagnosing autoimmune liver diseases

AU - Invernizzi, Pietro

AU - Lleo, Ana

AU - Podda, Mauro

PY - 2007/5

Y1 - 2007/5

N2 - Autoimmune liver diseases (ALD) are characterized by immune-mediated injury of bile ducts or hepatocytes, thus including cholangiopathies such as primary biliary cirrhosis (PBC), primary sclerosing cholangitis, and autoimmune hepatitis. Further, ALD variants manifesting with both hepatocellular and cholangiocellular damage are becoming more common. Serum autoantibodies, together with imaging and histology, are critical to the diagnostic process when ALD is suspected. Because an early diagnosis can influence prognosis, the development of sensitive and specific tests for serum autoantibodies should he a priority for researchers to ensure a more efficient noninvasive workup. Little prognostic value has been observed for any of the ALD serum hallmarks, and a vigorous effort to investigate new and old markers should therefore be undertaken in longitudinal studies as in the recent paradigm of PBC-specific antinuclear antibodies. We review herein the numerous ALD screening tests available in routine and specialized laboratories and comment on their significance in clinical practice.

AB - Autoimmune liver diseases (ALD) are characterized by immune-mediated injury of bile ducts or hepatocytes, thus including cholangiopathies such as primary biliary cirrhosis (PBC), primary sclerosing cholangitis, and autoimmune hepatitis. Further, ALD variants manifesting with both hepatocellular and cholangiocellular damage are becoming more common. Serum autoantibodies, together with imaging and histology, are critical to the diagnostic process when ALD is suspected. Because an early diagnosis can influence prognosis, the development of sensitive and specific tests for serum autoantibodies should he a priority for researchers to ensure a more efficient noninvasive workup. Little prognostic value has been observed for any of the ALD serum hallmarks, and a vigorous effort to investigate new and old markers should therefore be undertaken in longitudinal studies as in the recent paradigm of PBC-specific antinuclear antibodies. We review herein the numerous ALD screening tests available in routine and specialized laboratories and comment on their significance in clinical practice.

KW - Autoimmune hepatitis

KW - Overlap syndromes

KW - Primary biliary cirrhosis

KW - Primary sclerosing cholangitis

KW - Serum autoantibodies

UR - http://www.scopus.com/inward/record.url?scp=34249886050&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249886050&partnerID=8YFLogxK

U2 - 10.1055/s-2007-979469

DO - 10.1055/s-2007-979469

M3 - Article

C2 - 17520516

AN - SCOPUS:34249886050

VL - 27

SP - 161

EP - 172

JO - Seminars in Liver Disease

JF - Seminars in Liver Disease

SN - 0272-8087

IS - 2

ER -